Pharmaceutical Information |
Drug Name |
Sulfur hexafluoride |
Drug ID |
BADD_D02096 |
Description |
Sulfur hexafluoride is an ultrasound contrast agent indicated for use
•in echocardiography to opacify the left ventricular chamber and to improve the delineation of the left ventricular endocardial border in adult patients with suboptimal echocardiograms
•in ultrasonography of the liver for characterization of focal liver lesions in adult and pediatric patients |
Indications and Usage |
Echocardiography: Sulfur hexafluoride is indicated for use in adult patients with suboptimal echocardiograms to opacify the left ventricular chamber and to improve the delineation of the left ventricularendocardial border.
Ultrasonography of the Liver: Sulfur hexafluoride is indicated for use with ultrasound of the liver in adult and pediatric patients to characterize focal liver lesions. |
Marketing Status |
approved |
ATC Code |
Not Available |
DrugBank ID |
DB11104
|
KEGG ID |
D05962
|
MeSH ID |
D013459
|
PubChem ID |
17358
|
TTD Drug ID |
D0K0MI
|
NDC Product Code |
0270-7097; 0270-7099 |
UNII |
WS7LR3I1D6
|
Synonyms |
Sulfur Hexafluoride | Hexafluoride, Sulfur |
|
Chemical Information |
Molecular Formula |
F6S |
CAS Registry Number |
2551-62-4 |
SMILES |
FS(F)(F)(F)(F)F |
Chemical Structure |
|
|
ADRs Induced by Drug |
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
|
|